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Abstract
Objective: To examine the associations of maternal hemoglobin and hematocrit levels during
pregnancywith childhood lung function and asthma, andwhether adverse pregnancy outcomes
and atopic predisposition modify the associations.
Methods: In a population-based prospective cohort study among 3672 subjects, we measured
maternal hemoglobin and hematocrit levels in early pregnancy, and lung function by spirometry
and current asthma by questionnaire at age 10 years.
Results: Higher maternal hematocrit levels, both continuously and categorized into clinical cut-
offs, were associated with lower forced expiratory flow at 75%of forced vital capacity (FEF75) in
children (Z-score (95%CI):−0.04 (−0.07,−0.01), per increase of 1 SDS inhematocrit level; Z-score
(95%CI) difference: −0.11 (−0.20, −0.03) compared with normal hematocrit levels, respectively),
taking lifestyle and socio-economic factors into account. Adverse pregnancy outcomes and
atopic predisposition did not modify the results. No associations of maternal hemoglobin and
hematocrit with current asthma were observed.
Conclusion:Highermaternalhematocrit levelsduringpregnancyareassociatedwith lowerchildhood
lung function but not with risk of asthma. Adverse pregnancy outcomes and atopic predisposition
do not modify these associations. Underlying mechanisms need to be further studied.
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1 | INTRODUCTION
Preterm birth and low birth weight are associated with lower lung
function and increased risk of asthma in childhood.1–5 These
associations might be explained by intrauterine mechanisms such as
an inadequate oxygen and nutrients supply frommother to the fetus5–7
represented by lower or higher maternal hemoglobin and hematocrit
status during pregnancy.8–10 Lower or higher maternal hemoglobin and
hematocrit levels could lead to insufficient oxygen supply to the fetus,11
respectively, due to an increased hemodilution, or to an increased blood
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viscosity resulting in an impaired blood flow through the placenta.12
Subsequently, insufficient oxygen supply could affect fetal growth and
lung development,5,6,13–15 and increase the risk of chronic obstructive
respiratory diseases in later life.16,17
Human cohort studies that examined associations of maternal
hemoglobin and hematocrit status with asthma-related outcomes
in childhood are scarce, and report inconsistent results.16,17 A
prospective cohort study among 597 children and their mothers
showed that maternal anemia based on hemoglobin levels at any
time during pregnancy was associated with an increased risk of
infant wheezing and childhood asthma.16 In contrast, we previ-
ously observed no association of maternal hemoglobin levels
during pregnancy with wheezing from birth to age 6 years, ever
physician-diagnosed asthma, or change in respiratory resistance
(Rint) and fractional exhaled nitric oxide (FeNO) at 6 years.17
Differences in results of these studies might be explained by
differences in type of measurement of hemoglobin or hematocrit
levels, definitions of anemia such as hemoglobin level lower than
11 or 10.5 g/dL, type of lung function measures such as Rint,
FeNO, or peak expiratory flow, definitions of asthma such as
wheezing, ever or current asthma, ages at time of assessment, or
adjustment for confounders. Moreover, the role of socio-economic
and lifestyle factors, adverse pregnancy outcomes and atopic
predisposition on the association of maternal hemoglobin and
hematocrit status during pregnancy with asthma-related outcomes
in children is not fully clear.4,18
Therefore, we examined the associations of maternal hemoglobin
and hematocrit levels during pregnancy with lung function measures
and asthma among 3672 children participating in a population-based
prospective cohort, and whether these associations were explained by
lifestyle and socio-economic factors ormodified by adverse pregnancy
outcomes and atopic predisposition.
2 | METHODS
2.1 | Design
This study was embedded in the Generation R Study, a
prospective population-based cohort study from early fetal life
onwards in Rotterdam, the Netherlands.19–21 The study was
approved by the Medical Ethical Committee of the Erasmus MC,
University Medical Centre Rotterdam, the Netherlands. Written
informed consent was obtained from all participants. A total of
3672 mothers and their children were included for the current
analyses (Fig. 1).
2.2 | Maternal hemoglobin and hematocrit levels
during pregnancy
As previously described, we assessed maternal serum hemoglobin and
hematocrit levels from fresh EDTA plasma samples obtained by
maternal venous blood samples at enrolment.15 Of all blood samples,
>80% were obtained before 18 weeks of gestation (median 14.6
weeks [5-95% range: 11.0-22.7 weeks]). Samples were analyzed at
STAR Medisch Diagnostisch Centrum (Rotterdam, the
Netherlands).19,22 Using the World Health Organization (WHO)
criteria,23 anemia was defined as a serum hemoglobin level (Hb)
<6.83mmol/L or hematocrit level (Ht) <33%, which in our study
population reflected the lowest 12.3%. Similarly, elevated serum
hemoglobin and hematocrit levels were defined as the upper 12.3%
of the study population resulting in a hemoglobin higher than
8.19mmol/L or hematocrit higher than 39%. Normal levels were
defined as a serum hemoglobin level between 6.83mmol/L and
8.19mmol/L or hematocrit level between 33% and 39%. Standard
deviation scores (SDS) were constructed for hemoglobin and
hematocrit levels and used as continuous variables in our regression
models to obtain a more reliable comparison of the hemoglobin and
hematocrit levels within the data from the study population.
2.3 | Lung function and asthma
Spirometry was performed according to the American Thoracic
Society and European Respiratory Society recommendations24 in
9.8-year- (range: 8.6-12.0 years) old children. Lung function measures
included forced expiratory volume in 1 s (FEV1), forced vital capacity
(FVC), FEV1/FVC, forced expiratory flow at 25-75% of FVC (FEF25-75)
and forced expiratory flow at 75% of FVC (FEF75), andwere converted
into sex-, height-, age-, and ethnicity-adjusted Z-scores according to
the Global Lung Initiative reference data.25 Ever physician-diagnosed
asthma, wheezing, and use of inhalant medication in the past
12 months were reported by a parental questionnaire at age 9.8
years, adapted from the International Study on Asthma and Allergy in
Childhood (ISAAC).26 Current asthma was defined as ever physician
diagnosed asthma, with either wheezing or the use of inhalant
medication in the past 12 months.
n = 4,776
Children of mothers with
information on maternal
hematocrit (n = 4,726) and
hemoglobin (n = 4,776) levels
during pregnancy available
n = 6,181
Prenatally included singleton
children that participated in
postnatal phase at 10 years
n = 3,672
Children with information on
childhood lung function (n =
3,547) and current asthma (n =
3,520) available
n = 1,104
Missing information on lung
function measures and
current asthma diagnose
n = 1,405
Missing information on
maternal hematocrit and
hemoglobin levels during
pregnancy excluded
FIGURE 1 Flow chart of participants included for analysis
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2.4 | Covariates
Information on maternal characteristics included age, parity,
ethnicity, educational level, pre-pregnancy body mass index,
smoking during pregnancy, history of asthma and atopy, gestational
hypertensive disorders, folic acid supplementation during preg-
nancy, and alcohol consumption during pregnancy. All data were
obtained from questionnaires during pregnancy or from midwife and
hospital records at delivery.19 Mode of delivery and child’s sex,
gestational age at birth, and birth weight were obtained from
midwife and hospital records at birth.
2.5 | Statistical analysis
Independent T-test and chi-square test were used to compare all
characteristics of our population under study with those with missing
information on maternal hemoglobin and hematocrit levels during
pregnancy or those with missing information of lung function
measures and current asthma. For association analyses, we examined
the associations of maternal hemoglobin and hematocrit levels during
pregnancy with childhood lung function measures and asthma using
linear and logistic regression analysis. First, this model was adjusted for
gestational age at which maternal blood sampling occurred (crude
model).15 Second, we additionally adjusted for socio-economic factors
such asmaternal age, parity, educational level, and pre-pregnancy BMI
(model 1), and lifestyle factors such as folic acid supplementation and
alcohol consumption during pregnancy (model 2). Third, we adjusted
for all socio-economic and lifestyle factors (full model). Confounders
were selected based on literature, if they were associated with
hemoglobin and hematocrit levels andwith lung function or asthma, or
if the effect estimate of the crude analyses changed ≥10% when we
additionally adjusted for the confounder. Missing data in covariates
were imputed by the multiple imputation method using chained
equations to select the most likely value for a missing response.27
When data are missing not at random, bias in analysis based on
multiple imputation may be as large or larger than bias in analysis of
complete cases Missing data of covariates were imputed to reduce
bias and improve efficiency. Multiple imputation analysis aim to avoid
bias only if enough variables predictive of missing values are included
in the imputation model.28 Therefore, we included variables used in
the multivariate models, and additionally important variables that
could correctly predict the missing values including socio-economic
factors (family income, paternal education level, maternal ethnicity,
and child day care attendance in the first year of life) and biological
factors (maternal smoking, atopy and asthma family history, mode of
delivery, gestational age at birth, breastfeeding, and maternal weight
and height at enrolment). Non-linear associations were tested by
adding the quadratic term for hemoglobin and hematocrit levels in the
models. We used similar regression analyses for the associations of
low and elevated hemoglobin and hematocrit levels with lung function
measures and current asthma, using normal hemoglobin and hemato-
crit levels as reference categories. Last, effect modification due to
adverse pregnancy outcomes (caesarian section, lower gestational
age, or weight at birth), and atopic predisposition factors (maternal
history of asthma or atopy and child’s allergic sensitization) were
examined in the fully adjusted models by adding the product term
between the determinant and the covariate in the statistical models.
We used the F-statistic to test the model fit of models with and
without interaction terms. P values for F-statistics <0.05 were
considered significant, indicating a different model fit when comparing
the models with and without interaction terms. All measures
of association are presented with their 95% Confidence Intervals
(95%CI). Statistical analyses were performed using SPSS version 21.0
for Windows software (SPSS Inc, Chicago, IL).
3 | RESULTS
Maternal and child characteristics are presented in Table 1. Mean
maternal hemoglobin and hematocrit levels were 7.56mmol/L
(SD ± 0.61) and 36% (SD ± 3.00), respectively. Based on hemoglobin
and hematocrit levels, respectively, 12.2% and 17.5% of the mothers
were anemic, and 15% and 16.8% had elevated Hb or Ht levels. Mean
absolute values for FEV1, FVC, FEV1/FVC, FEF25-75, and FEF75 of the
children were 2.02 L (SD ± 0.30), 2.33 L (SD ± 0.36), 0.87 (SD ± 0.06),
2.71 L/s (SD ± 0.64), and 1.14 L/s (SD ± 0.34), respectively. Current
asthma was observed in 7.2% of the participants. Compared with
those included in our study, we observed that mothers not included in
the study were younger, more often multiparous, had a higher pre-
pregnancy BMI, more often had gestational hypertensive disorders,
less often used folic acid supplementation and alcohol during
pregnancy, more often had caesarean-section as mode of delivery
of their child, and that children were born at an earlier gestational age
(P values <0.01) (Table S1).
3.1 | Hemoglobin and hematocrit levels and
respiratory outcomes
The crude model showed that higher maternal hemoglobin levels
were associated with lower FEF25-75 and FEF75 in children (Z-score
[95%CI]: −0.05 [−0.09, −0.01] and −0.05 [−0.08, −0.02], respec-
tively, per increase of 1 SDS in hemoglobin level), and that higher
maternal hematocrit levels were associated with lower FEV1/FVC
and FEF75 in children (−0.04 [−0.07, −0.01] and −0.05 [−0.08, −0.02],
respectively, per increase of 1 SDS in hematocrit level) (Table 2).
Maternal hemoglobin and hematocrit levels were not associated
with FEV1, FVC or current asthma. The effect estimates of
associations of maternal hemoglobin with FEF25-75 and FEF75, and
of associations of maternal hematocrit level with FEV1/FVC
attenuated into significant when socio-economic (model 1) and
lifestyle factors (model 2), respectively, were taken into account.
After adjusting for both socio-economic and lifestyle factors (full
model), only the association of a higher maternal hematocrit level
during pregnancy with a lower childhood FEF75 remained (−0.04
[−0.07, −0.01], per increase of 1 SDS in hematocrit level). Based on
hemoglobin clinical cut-offs, maternal anemia during pregnancy was
associated with a high FEF25-75 (difference in Z-score [95%CI]: 0.16
[0.05, 0.27]) when compared to normal hemoglobin levels (Fig. 2D,
Table S2). Based on hematocrit clinical cut-offs, an elevated
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maternal hematocrit level during pregnancy was associated with a
low FEF75 (difference in Z-score [95%CI]: −0.11 [−0.20, −0.03])
when compared to normal hematocrit levels (Fig. 2E, Table S2).
Maternal anemia or elevated hemoglobin or hematocrit levels were
not associated with FEV1, FVC, FEV1/FVC, or current asthma in
children (Fig. 2A-C, Table S2).
We did not observe any non-linear associations of maternal
hemoglobin and hematocrit levels with childhood lung function or
asthma (data not shown, P values for quadratic term >0.05). We did
not observe modifying effects of maternal mode of delivery, child’s
gestational age and weight at birth, maternal history of asthma or
atopy and child’s allergic sensitization for the associations of
maternal hemoglobin or hematocrit level with childhood lung
function measures or current asthma (P values for interaction
>0.05, P values for F-statistics >0.05).
4 | DISCUSSION
In this population-based prospective birth cohort study, we observed
that higher maternal hematocrit levels during pregnancy, both continu-
ously and categorized according to clinical cut-offs, were associatedwith
TABLE 1 Characteristics of mothers and their children (n = 3672)
Original data
Imputed
data
Maternal characteristics
Age (years) 30.9 (4.84) 30.9 (4.84)
Parity (%)
Nullipara 58.4 (2131) 58.4 (2145)
Multipara 41.6 (1518) 41.6 (1527)
Missing 0.6 (23)
Ethnicity (%)
European 65.2 (2346) 64.6 (2373)
Non-European 34.8 (1254) 35.4 (1299)
Missing 2.0 (72)
Education level (%)
Less than secondary level 48.8 (1702) 49.9 (1832)
Higher 51.2 (1786) 50.1 (1840)
Missing 5.0 (184)
Prepregnancy body mass index
(kg/m2)
24.54 (4.23) 24.54 (4.23)
Smoking during pregnancy (%)
No 76.2 (2513) 76.2 (2797)
Yes 23.8 (786) 23.8 (875)
Missing 5.0 (184)
History of asthma or atopy (%)
No 62.3 (2014) –
Yes 37.7 (1220) –
Missing 11.9 (438) –
Gestational hypertensive disorders (%)
No 96.3 (3366) 96.0 (3525)
Yes 3.7 (130) 4.0 (147)
Missing 4.8 (176)
Folic acid supplementation (%)
No 21.7 (621) 23.3 (856)
Start 1st 10 weeks of gestation 30.8 (879) 31.2 (1145)
Start periconceptional 47.5 (1357) 45.5 (1671)
Missing 22.2 (815)
Alcohol consumption during pregnancy (%)
None 42.6 (1390) 43.0 (1580)
Any 57.4 (1872) 57.0 (2091)
Missing 11.2 (410)
Mode of delivery (%)
Vaginal 88.1 (2941) 88.2 (3239)
Caeserean-section 11.9 (396) 11.8 (433)
Missing 9.1 (335)
Hemoglobin (mmol/L) 7.56 (0.61) –
Hemoglobin clinical categories (%)
Anemia (<6.83mmol/L) 12.0 (442) –
Normal (6.83-8.20mmol/L) 72.8 (2672) –
Elevated hemoglobin
(>8.20mmol/L)
15.2 (558) –
(Continues)
TABLE 1 (Continued)
Original data
Imputed
data
Hematocrit 0.36 (0.03) –
Hematocrit clinical categories (%)
Anemia (<33%) 17.6 (640) –
Normal (33-39%) 65.4 (2376) –
Elevated hematocrit (>39%) 16.9 (615) –
Child’s characteristics
Female sex (%) 51.7 (1900) 51.7 (1900)
Gestational age at birth
(weeks)
39.94 (1.71) 39.94 (1.71)
Birth weight (grams) 3442.39
(541.91)
3441.57
(543.2)
Breastfeeding (%)
No 6.9 (209) 7.3 (267)
Yes 93.1 (2816) 92.7 (3405)
Missing 17.6 (647)
Age 9.79 (0.34) 9.79 (0.34)
FEV1 2.02 (0.30) –
FVC 2.33 (0.36) –
FEV1/FVC 0.87 (0.06) –
FEF25-75 2.71 (0.64) –
FEF75 1.14 (0.34) –
Current asthma
No 92.7 (2781) –
Yes 7.3 (219) –
Missing 18.3 (672) –
Values are means (SD) or valid percentages (absolute numbers).
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lower FEF75 in children taking lifestyle and socio-economic factors into
account.Maternal anemia during pregnancy based on hemoglobin levels
was associated with a high FEF25-75, compared to normal hemoglobin
levels. Results were not modified by adverse pregnancy outcomes and
atopic predisposition. We did not observe any associations of maternal
hemoglobinandhematocrit levelswith current asthma, although residual
confounders might affect our findings.
4.1 | Comparison with previous studies
Prospective cohort studies that assessed the association of maternal
hemoglobin or hematocrit levels with childhood lung function and
asthma are scarce,16,17 and show inconsistent results. We aimed to
address all factors that explained differences in results of the previous
studies into account, and now used both hemoglobin and hematocrit
levels, WHO clinical cut-off definitions, lung function measured by
spirometry, which is an objective and reliable29,30 method, took
gestational age at blood sampling and multiple confounders into
account, and explored intermediating and effect modifying factors.We
observed associations of maternal hemoglobin and hematocrit levels
measured in early pregnancy with lower childhood lung function, but
not with asthma at age 10 years. A population based cohort study
among 597 children and their mothers observed associations of
maternal anemia in late pregnancy with wheezing and asthma until age
6 years, howeverwedid not.Main differences between the studies that
could explain the different findings are the period during pregnancy at
which hemoglobin and hematocrit blood levels were measured, in the
first pregnancy versus at delivery, the adjustment for gestational age at
blood sampling or not, and the determinants definitions. Previous
studies have shown that hemoglobin or hematocrit levels might change
according to the pregnancy trimester evaluated23 and that mothers are
more likely to develop anemia in the third trimester.31 Period in
pregnancy at which maternal anemia is measured seems therefore
important.Also, the age atwhich asthmawasmeasured, anddifferences
in studypopulations, a high-risk asthmapopulation versus a population-
based cohort, might have influenced differences in results.
Maternal iron status during pregnancymay be used as proxy of the
overall maternal nutritional status and also as a proxy of maternal
anemia, since iron deficiency is a very common cause of anemia.8 A
previous study that examined the association of iron levels during
pregnancy with asthma-related outcomes in children32 suggested that
lower maternal iron levels during pregnancy are associated with
increased risks of wheezing and atopic sensitization in children
whereas higher maternal iron levels during pregnancy are related to
better lung functionmeasures. Therefore, future studies need to focus
on maternal hemoglobin and hematocrit in combination with iron
levels status during multiple trimesters of pregnancy and the
association with childhood lung function and asthma.
4.2 | Interpretation of results
The associations of maternal hemoglobin and hematocrit levels during
pregnancy with childhood lung function might be explained by the
importance of adequate oxygen and nutrients supply from the mother
to the fetus in order to guarantee an adequate general and lung growth
anddevelopment.5–7 Lowmaternal hemoglobin levelsmay represent an
insufficient oxygen supply to the fetus since the hemoglobinmolecule is
the oxygen carrier in our body.33 High hemoglobin or hematocrit levels
during pregnancy may lead to an important increase in the blood
viscosity inducing an impaired blood flow through the placenta and,
therefore, an insufficient oxygen supply to the fetus. Animal models
have shown that undernutrition and hypoxia lead to an impaired lung
development.34,35 In sheep, it has been shown that intrauterine
exposure to hypoxia may inhibit lung growth and DNA synthesis.34 A
study in lambs fetuses showed that hypoxemia decreases pulmonary
blood flow, which might lead to reduced oxygen and nutrients supply
that could have an adverse impact on lung development.35
TABLE 2 Associations of maternal hemoglobin and hematocrit levels with childhood lung function measures and asthma
FEV1
Z-score (95%CI)
FVC
Z-score (95%CI)
FEV1/FVC
Z-score (95%CI)
FEF25-75
Z-score (95%CI)
FEF75
Z-score (95%CI)
Current asthma
OR (95%CI)
Hemoglobin (SDS)
Crude
modela
−0.02 (−0.05, 0.02) −0.00 (−0.03, 0.03) −0.03 (−0.07, 0.00) −0.05 (−0.09, −0.01)* −0.05 (−0.08, −0.02)** 1.00 (0.86, 1.17)
Model 1b −0.02 (−0.06, 0.02) −0.01 (−0.05, 0.02) −0.02 (−0.06, 0.01) −0.05 (−0.09, −0.01)* -0.04 (-0.07, −0.01)* 1.01 (0.86, 1.18)
Model 2c −0.01 (−0.04, 0.03) 0.00 (−0.03, 0.04) −0.02 (−0.06, 0.01) −0.04 (−0.08, 0.00) −0.03 (−0.06, 0.00) 1.02 (0.87, 1.19)
Full modeld −0.02 (−0.05, 0.02) −0.01 (−0.04, 0.03) −0.02 (−0.05, 0.02) −0.04 (−0.08, 0.00) −0.03 (−0.07, 0.00) 1.01 (0.87, 1.18)
Hematocrit (SDS)
Crudea −0.02 (−0.05, 0.02) 0.00 (−0.03, 0.03) −0.04 (−0.07, −0.01)* −0.04 (−0.07, 0.00) −0.05 (−0.08, −0.02)** 1.01 (0.87, 1.17)
Model 1b −0.02 (−0.06, 0.01) −0.01 (−0.04, 0.02) −0.03 (−0.07, 0.00) −0.03 (−0.07, 0.01) −0.05 (−0.08, −0.02)** 1.01 (0.87, 1.17)
Model 2c −0.01 (−0.04, 0.03) 0.01 (−0.03, 0.04) −0.03 (−0.07, 0.00) −0.02 (−0.06, 0.01) −0.04 (−0.07, −0.01)* 1.02 (0.83, 1.19)
Full modeld −0.02 (0.02, 0.00) −0.01 (−0.04, 0.03) −0.03 (−0.06, 0.01) −0.03 (−0.07, 0.01) −0.04 (−0.07, −0.01)* 1.01 (0.87, 1.18)
Values reflect changes in Z-scores or odds ratios (OR) with their 95% Confidence Interval per increase of one SDS hemoglobin or hematocrit *P-value <0.05,
**P-value <0.01.
aAdjusted for gestational age at maternal blood sampling.
bCrude model additionally adjusted for maternal age, parity, educational level, pre-pregnancy BMI.
cCrude model additionally adjusted for maternal folic acid supplementation and alcohol consumption during pregnancy.
dAdjusted for all confounders.
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It has been suggested that in some circumstances the
physiological plasma-volume expansion that usually occur in
pregnancy may fail which could lead to relatively elevated
hemoglobin or hematocrit levels during pregnancy.36,37 This would
imply more viscous blood and could potentially lead to impaired
placental perfusion and inappropriate blood and nutrients supply to
the fetus. Our study showed that maternal elevated hematocrit
levels were associated with lower lung function measures and might
support the proposed hypothesis that maternal blood hyper
viscosity during pregnancy influences fetal growth and lung
development and later life lower lung function.
We observed that maternal anemia was associated with a high
FEF25-75 in children. We analyzed hemoglobin and hematocrit
levels mostly from blood samples obtained in the first trimester of
pregnancy but hemoglobin or hematocrit levels might change
according to the pregnancy trimester evaluated.23 During early
pregnancy, the mother is exposed to normal hemodynamic
changes with an increase in the blood plasma disproportionally
greater than increase of blood red cells numbers, which results in a
physiologic anemia. Cohort studies have suggested that maternal
physiologic anemia and iron deficiency anemia, which more often
occurs in the third trimester,31 might have different consequences
to child health.9,10,32 Iron deficiency seems associated with
adverse child health outcomes while physiologic anemia seems
to be associated with better outcomes for mother and child. Our
results are in line with this hypothesis, although we were unable to
assess the role of maternal iron status during pregnancy on lung
function and asthma in children. It has also been suggested that the
placenta might adapt to lower levels of hemoglobin or hematocrit
leading to an increase in its vascular density.11 This adaptive
response could enhance fetal development, and our findings of
maternal anemia leading to a high FEF25-75 could be attributed to
this mechanism.
4.3 | Strengths and limitations
We used a population-based prospective cohort design from early
pregnancy onwards, with detailed information on maternal and child
characteristics and on maternal red blood status. Spirometry is the
preferredmethod to assess lung function,29,30,38 and to date this is the
first study that uses this method as asthma-related outcome with
maternal hemoglobin and hematocrit levels during pregnancy and
long-term pulmonary outcomes under study. However, some limi-
tations do apply. First, subjects lost to follow-up had less favorable
social-economic status and lifestyle characteristics than those
included in our study. This could have led to selection bias if the
associations of maternal hemoglobin and hematocrit levels during
pregnancy with childhood lung function and asthma would have been
different between those subjects included and those lost to follow-up.
This seems unlikely, but needs to be considered. Additionally, we did
not observe any differences between complete case analysis and
multiple imputation, which suggests that any non-randommissing data
did not affect our results.28 Second, we used self-reported data to
define current asthma in our study population. Although we used
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FIGURE 2 Associations of clinical cut-offs of maternal hemoglobin and hematocrit levels with childhood FEV1 (A), FVC (B), FEV1/FVC (C),
FEF25-75 (D), FEF75 (E), and current asthma (F). Values reflect changes in Z-scores or odds ratios (OR) with their 95% Confidence Interval.
Reference group are those mothers with a normal hemoglobin or hematocrit level. Models are adjusted for gestational age at maternal blood
sampling, maternal age, parity, educational level, pre-pregnancy BMI, folic acid supplementation, and alcohol consumption during pregnancy.
*P-value < 0.05, **P-value < 0.01
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questions previously validated in other cohorts studies and commonly
used in epidemiological studies, we cannot exclude the possibility of
under- or over-reporting, which could have led to misclassification of
the asthma outcome and, thus, to under- or over-estimations of the
true associations. Third, although we have included many potential
confounders in our analysis, it is possible that residual confounding
such as nutritional factors remains an issue in our study. Last, we
observed most consistent associations of maternal hematocrit levels
with FEF75 but not with other lung function measures or current
asthma. It has been shown that FEF75 correlates more closely to mild
or moderate asthma whereas FEV1 with more severe asthma cases.
38
Therefore, in our population-based study, we might have had a higher
prevalence of mild and moderate asthma, reflected by FEF75, than
severe asthma cases, which has consequences for the generalizability
of our results. Furthermore, our current asthma definition did not
include spirometry values, which might have been normal due to
treatment. Also, current asthma was measured subjectively by
parental reports while lung function objectively by spirometry, which
might partly explain the absence of associations of maternal
hemoglobin and hematocrit levels with asthma diagnose itself.
In conclusion, our study suggests that higher maternal hematocrit
levels are associated with lower lung function, and maternal anemia in
early pregnancywith higher lung function in childhood. Results are partly
explained by lifestyle and socio-economic factors, and not modified by
adverse pregnancy outcomes or atopic predisposition. Future studies are
needed to explore whether maternal hemoglobin or hematocrit levels
during pregnancy are associated with lung function and asthma in later
life, and to explore potential underlying nutritional factors.
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